Scinai Immunotherapeutics annual capital expenditures (capex)
2017
2020
2021
2022
2023
2024
2025
Scinai Immunotherapeutics Capital Expenditures (CapEx) Growth & History (SCNI)
Scinai Immunotherapeutics's capital expenditures (capex) was $24,000 for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $24,000 | $12,000 | +100.00% |
| 2024 | 2024-12-31 | $12,000 | −$625,000 | −98.12% |
| 2023 | 2023-12-31 | $637,000 | −$199,000 | −23.80% |
| 2022 | 2022-12-31 | $836,000 | $698,000 | +505.80% |
| 2021 | 2021-12-31 | $138,000 | −$1.8M | −92.76% |
| 2020 | 2020-12-31 | $1.9M | — | — |
| 2017 | 2017-12-31 | $1.3M | — | — |
Scinai Immunotherapeutics quarterly capital expenditures (capex)
Q1.22
Q2.22
Q1.23
Q2.23
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $112,000 | $109,000 | +3633.33% |
| Q1 2026 | 2026-03-31 | $3,000 | −$6,000 | −66.67% |
| Q2 2025 | 2025-06-30 | $3,000 | — | — |
| Q1 2025 | 2025-03-31 | $9,000 | — | — |
| Q2 2023 | 2023-06-30 | $377,000 | $342,000 | +977.14% |
| Q1 2023 | 2023-03-31 | $6,000 | −$515,000 | −98.85% |
| Q2 2022 | 2022-06-30 | $35,000 | — | — |
| Q1 2022 | 2022-03-31 | $521,000 | — | — |
Scinai Immunotherapeutics capital expenditures (capex) trends
Over the last five fiscal years, Scinai Immunotherapeutics's capital expenditures (capex) decreased from $1.9M to $24,000, a change of −$1.9M. The latest reported quarter, Q2 2026, shows $112,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗